Acute Liver Failure

Priyanka Rajaram; Ram Subramanian

doi:10.1055/s-0038-1673372

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2018; 39(05): 513-522
DOI: 10.1055/s-0038-1673372

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Acute Liver Failure

Priyanka Rajaram

¹Department of Medicine, Emory University School of Medicine, Atlanta, Georgia

,

Ram Subramanian

¹Department of Medicine, Emory University School of Medicine, Atlanta, Georgia

› Author Affiliations

Abstract

Acute liver failure (ALF) is a condition that can rapidly progress to multiorgan failure. This article focuses on the diagnosis and management of ALF. We provide a detailed review of the common etiologies of ALF, including acetaminophen overdose, viral hepatitis, drug-induced liver injury, Wilson's disease, and autoimmune hepatitis. The article then addresses how to recognize ALF and reviews the role of common laboratory and imaging tests in establishing this diagnosis. The remainder of the article details the management of hepatic and extrahepatic organ dysfunctions in ALF. The article concludes with a discussion regarding the prognostication of patients with ALF and the criteria for considering liver transplantation.

Keywords

acute liver failure - hepatic encephalopathy - acute renal failure - intracranial hypertension - acetaminophen toxicity

Full Text

References

References
1 Blackmore L, Bernal W. Acute liver failure. Clin Med (Lond) 2015; 15 (05) 468-472
2 Cardoso FS, Marcelino P, Bagulho L, Karvellas CJ. Acute liver failure: an up-to-date approach. J Crit Care 2017; 39: 25-30
3 Kandiah PA, Olson JC, Subramanian RM. Emerging strategies for the treatment of patients with acute hepatic failure. Curr Opin Crit Care 2016; 22 (02) 142-151
4 Bernal W, Auzinger G, Sizer E, Wendon J. Intensive care management of acute liver failure. Semin Liver Dis 2008; 28 (02) 188-200
5 Bernsmeier C, Antoniades CG, Wendon J. What's new in acute liver failure?. Intensive Care Med 2014; 40 (10) 1545-1548
6 Baudouin SV, Howdle P, O'Grady JG, Webster NR. Acute lung injury in fulminant hepatic failure following paracetamol poisoning. Thorax 1995; 50 (04) 399-402
7 Koch DG, Speiser JL, Durkalski V. , et al. The natural history of severe acute liver injury. Am J Gastroenterol 2017; 112 (09) 1389-1396
8 Lee WM, Squires Jr RH, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology 2008; 47 (04) 1401-1415
9 Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011. Hepatology 2012; 55 (03) 965-967
10 Gulmez SE, Larrey D, Pageaux GP. , et al. Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case-population SALT study. Drug Saf 2013; 36 (02) 135-144
11 Brok J, Buckley N, Gluud C. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev 2006; (02) CD003328
12 Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. BMJ 1979; 2 (6198): 1097-1100
13 Yang R, Miki K, He X, Killeen ME, Fink MP. Prolonged treatment with N-acetylcysteine delays liver recovery from acetaminophen hepatotoxicity. Crit Care 2009; 13 (02) R55
14 Bailey B, Amre DK, Gaudreault P. Fulminant hepatic failure secondary to acetaminophen poisoning: a systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med 2003; 31 (01) 299-305
15 Lee WM, Hynan LS, Rossaro L. , et al; Acute Liver Failure Study Group. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009; 137 (03) 856-864 , 864.e1
16 Shalimar, Acharya SK. Management in acute liver failure. J Clin Exp Hepatol 2015; 5 (Suppl. 01) S104-S115
17 Singh S, Hynan LS, Lee WM. ; Acute Liver Failure Study Group. Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage non-acetaminophen acute liver failure. Dig Dis Sci 2013; 58 (05) 1397-1402
18 Habib S, Shaikh OS. Drug-induced acute liver failure. Clin Liver Dis 2017; 21 (01) 151-162
19 Ichai P, Laurent-Bellue A, Saliba F. , et al. Acute liver failure/injury related to drug reaction with eosinophilia and systemic symptoms: outcomes and prognostic factors. Transplantation 2017; 101 (08) 1830-1837
20 Thiim M, Friedman LS. Hepatotoxicity of antibiotics and antifungals. Clin Liver Dis 2003; 7 (02) 381-399 , vi–vii
21 Russo MW, Scobey M, Bonkovsky HL. Drug-induced liver injury associated with statins. Semin Liver Dis 2009; 29 (04) 412-422
22 Mumtaz K, Azam Z, Hamid S. , et al. Role of N-acetylcysteine in adults with non-acetaminophen-induced acute liver failure in a center without the facility of liver transplantation. Hepatol Int 2009; 3 (04) 563-570
23 Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci 2011; 56 (04) 958-976
24 Dignan FL, Wynn RF, Hadzic N. , et al; Haemato-oncology Task Force of British Committee for Standards in Haematology; British Society for Blood and Marrow Transplantation. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol 2013; 163 (04) 444-457
25 Bismuth H, Samuel D, Castaing D. , et al. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 1995; 222 (02) 109-119
26 Jayakumar S, Chowdhury R, Ye C, Karvellas CJ. Fulminant viral hepatitis. Crit Care Clin 2013; 29 (03) 677-697
27 Noor A, Panwala A, Forouhar F, Wu GY. Hepatitis caused by herpes viruses: a review. J Dig Dis 2018
28 O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97 (02) 439-445
29 Younis BB, Arshad R, Khurhsid S, Masood J, Nazir F, Tahira M. Fulminant hepatic failure (FHF) due to acute hepatitis C. Pak J Med Sci 2015; 31 (04) 1009-1011
30 Lightsey JM, Rockey DC. Current concepts in ischemic hepatitis. Curr Opin Gastroenterol 2017; 33 (03) 158-163
31 Ma M, Falloon K, Chen PH. , et al. The role of liver transplantation in alcoholic hepatitis. J Intensive Care Med 2018 Doi: 10.1177/0885066618780339
32 Bernuau J, Goudeau A, Poynard T. , et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986; 6 (04) 648-651
33 Wang CY, Zhao P, Liu WW. ; Acute Liver Failure Study Team. Acute liver failure caused by severe acute hepatitis B: a case series from a multi-center investigation. Ann Clin Microbiol Antimicrob 2014; 13: 23
34 Frias M, López-López P, Rivero A, Rivero-Juarez A. Role of hepatitis E virus infection in acute-on-chronic liver failure. BioMed Res Int 2018; 2018: 9098535
35 Seijo S, Plessier A, Hoekstra J. , et al; European Network for Vascular Disorders of the Liver. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology 2013; 57 (05) 1962-1968
36 Zhang F, Wang C, Li Y. The outcomes of interventional treatment for Budd-Chiari syndrome: systematic review and meta-analysis. Abdom Imaging 2015; 40 (03) 601-608
37 Rizvi S, Gawrieh S. Autoimmune hepatitis in the elderly: diagnosis and pharmacologic management. Drugs Aging 2018; 35 (07) 589-602
38 Singanayagam A, Bernal W. Update on acute liver failure. Curr Opin Crit Care 2015; 21 (02) 134-141
39 Yasui S, Fujiwara K, Yonemitsu Y, Oda S, Nakano M, Yokosuka O. Clinicopathological features of severe and fulminant forms of autoimmune hepatitis. J Gastroenterol 2011; 46 (03) 378-390
40 Pfeiffenberger J, Weiss KH, Stremmel W. Wilson disease: symptomatic liver therapy. Handb Clin Neurol 2017; 142: 205-209
41 Huang Y, Takatsuki M, Soyama A. , et al. Living donor liver transplantation for Wilson's disease associated with fulminant hepatic failure: a case report. Am J Case Rep 2018; 19: 304-308
42 Khan R, Koppe S. Modern management of acute liver failure. Gastroenterol Clin North Am 2018; 47 (02) 313-326
43 Collado Ferrer M, Collado Ferrer L, Serrano A. Acute fatty liver of pregnancy. Bol Asoc Med P R 2010; 102 (04) 51-53
44 Ronen J, Shaheen S, Steinberg D, Justus KR. Acute fatty liver of pregnancy: a thorough examination of a harmful obstetrical syndrome and its counterparts. Cureus 2018; 10 (02) e2164
45 Rabinowich L, Wendon J, Bernal W, Shibolet O. Clinical management of acute liver failure: results of an international multi-center survey. World J Gastroenterol 2016; 22 (33) 7595-7603
46 Bernal W, Hyyrylainen A, Gera A. , et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol 2013; 59 (01) 74-80
47 Nakao M, Nakayama N, Uchida Y. , et al. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan. J Gastroenterol 2018; 53 (06) 752-769
48 Bernal W, Williams R. Beyond KCH selection and options in acute liver failure. Hepatol Int 2018; 12 (03) 204-213
49 Fikatas P, Lee JE, Sauer IM. , et al. APACHE III score is superior to King's College Hospital criteria, MELD score and APACHE II score to predict outcomes after liver transplantation for acute liver failure. Transplant Proc 2013; 45 (06) 2295-2301
50 Cordoba J. Hepatic encephalopathy: from the pathogenesis to the new treatments. ISRN Hematol 2014; 2014: 236268
51 Ciećko-Michalska I, Szczepanek M, Słowik A, Mach T. Pathogenesis of hepatic encephalopathy. Gastroenterol Res Pract 2012; 2012: 642108
52 Salgado M, Cortes Y. Hepatic encephalopathy: etiology, pathogenesis, and clinical signs. Compend Contin Educ Vet 2013; 35 (06) E1-E8 , quiz E9
53 Toris GT, Bikis CN, Tsourouflis GS, Theocharis SE. Hepatic encephalopathy: an updated approach from pathogenesis to treatment. Med Sci Monit 2011; 17 (02) RA53-RA63
54 Basile AS, Jones EA. Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy. Hepatology 1997; 25 (06) 1303-1305
55 Bosoi CR, Rose CF. Elevated cerebral lactate: implications in the pathogenesis of hepatic encephalopathy. Metab Brain Dis 2014; 29 (04) 919-925
56 Maddison JE. Hepatic encephalopathy. Current concepts of the pathogenesis. J Vet Intern Med 1992; 6 (06) 341-353
57 Desjardins P, Du T, Jiang W, Peng L, Butterworth RF. Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure: role of glutamine redefined. Neurochem Int 2012; 60 (07) 690-696
58 Häussinger D. [Hepatic encephalopathy: clinical aspects and pathogenesis]. Dtsch Med Wochenschr 2004; 129 (Suppl. 02) S66-S67
59 Shawcross DL, Shabbir SS, Taylor NJ, Hughes RD. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology 2010; 51 (03) 1062-1069
60 Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 2007; 46 (06) 1844-1852
61 Quero Guillén JC, Carmona Soria I, García Montes JM, Jiménez Sáenz M, Herrerías Gutiérrez JM. Hepatic encephalopathy: nomenclature, pathogenesis and treatment. Rev Esp Enferm Dig 2003; 95 (02) 135-142 , 127–134
62 Bernal W, Wendon J. Acute liver failure. N Engl J Med 2013; 369 (26) 2525-2534
63 Larson AM. Diagnosis and management of acute liver failure. Curr Opin Gastroenterol 2010; 26 (03) 214-221
64 Davenport A. Management of acute kidney injury in liver disease. Contrib Nephrol 2010; 165: 197-205
65 Davenport A. Continuous renal replacement therapies in patients with liver disease. Semin Dial 2009; 22 (02) 169-172
66 Davenport A. Continuous renal replacement therapy for liver disease. Hemodial Int 2003; 7 (04) 348-352
67 Davenport A, Sheikh MF, Lamb E, Agarwal B, Jalan R. Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit?. Kidney Int 2017; 92 (05) 1058-1070
68 O'Brien Z, Cass A, Cole L. , et al; RENAL Study Investigators and the Australian and New Zealand Intensive Care Clinical Trials Group. Higher versus lower continuous renal replacement therapy intensity in critically ill patients with liver dysfunction. Blood Purif 2018; 45 (1-3): 36-43
69 Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 1993; 21 (03) 328-338
70 Gupta S, Fenves AZ, Hootkins R. The role of RRT in hyperammonemic patients. Clin J Am Soc Nephrol 2016; 11 (10) 1872-1878
71 Ede RJ, Gimson AE, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol 1986; 2 (01) 43-51
72 Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993; 341 (8838): 157-158
73 Karvellas CJ, Fix OK, Battenhouse H, Durkalski V, Sanders C, Lee WM. ; U S Acute Liver Failure Study Group. Outcomes and complications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study. Crit Care Med 2014; 42 (05) 1157-1167
74 Vaquero J, Fontana RJ, Larson AM. , et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 2005; 11 (12) 1581-1589
75 Stravitz RT, Kramer AH, Davern T. , et al; Acute Liver Failure Study Group. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med 2007; 35 (11) 2498-2508
76 Rajajee V, Fontana RJ, Courey AJ, Patil PG. Protocol based invasive intracranial pressure monitoring in acute liver failure: feasibility, safety and impact on management. Crit Care 2017; 21 (01) 178
77 Krisl JC, Meadows HE, Greenberg CS, Mazur JE. Clinical usefulness of recombinant activated factor VII in patients with liver failure undergoing invasive procedures. Ann Pharmacother 2011; 45 (11) 1433-1438
78 Rajajee V, Williamson CA, Fontana RJ, Courey AJ, Patil PG. Noninvasive intracranial pressure assessment in acute liver failure. Neurocrit Care 2018
79 Polson J, Lee WM. ; American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology 2005; 41 (05) 1179-1197
80 Diringer MN, Zazulia AR. Osmotic therapy: fact and fiction. Neurocrit Care 2004; 1 (02) 219-233
81 Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004; 39 (02) 464-470
82 Canalese J, Gimson AE, Davis C, Mellon PJ, Davis M, Williams R. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut 1982; 23 (07) 625-629
83 Jalan R, Olde Damink SW, Deutz NE, Hayes PC, Lee A. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology 2004; 127 (05) 1338-1346
84 Larson AC, Jamrogowicz JL, Kulikowicz E. , et al. Cerebrovascular autoregulation after rewarming from hypothermia in a neonatal swine model of asphyxic brain injury. J Appl Physiol (1985) 2013; 115 (10) 1433-1442
85 Karvellas CJ, Todd Stravitz R, Battenhouse H, Lee WM, Schilsky ML. ; US Acute Liver Failure Study Group. Therapeutic hypothermia in acute liver failure: a multicenter retrospective cohort analysis. Liver Transpl 2015; 21 (01) 4-12
86 Saigal S, Sharma JP, Dhurwe R, Kumar S, Gurjar M. Targeted temperature management: current evidence and practices in critical care. Indian J Crit Care Med 2015; 19 (09) 537-546
87 Vaquero J. Therapeutic hypothermia in the management of acute liver failure. Neurochem Int 2012; 60 (07) 723-735
88 Tofteng F, Larsen FS. The effect of indomethacin on intracranial pressure, cerebral perfusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 2004; 24 (07) 798-804
89 Wigmore SJ, Walsh TS, Lee A, Ross JA. Pro-inflammatory cytokine release and mediation of the acute phase protein response in fulminant hepatic failure. Intensive Care Med 1998; 24 (03) 224-229
90 Tranah TH, Vijay GK, Ryan JM, Shawcross DL. Systemic inflammation and ammonia in hepatic encephalopathy. Metab Brain Dis 2013; 28 (01) 1-5
91 Zider AD, Zopey R, Garg R, Wang X, Wang TS, Deng JC. Prognostic significance of infections in critically ill adult patients with acute liver injury: a retrospective cohort study. Liver Int 2016; 36 (08) 1143-1150
92 Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infection in acute liver failure. Semin Liver Dis 1996; 16 (04) 389-402
93 Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000; 32 (4 Pt 1): 734-739
94 Wade J, Rolando N, Philpott-Howard J, Wendon J. Timing and aetiology of bacterial infections in a liver intensive care unit. J Hosp Infect 2003; 53 (02) 144-146
95 Vaquero J, Polson J, Chung C. , et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 2003; 125 (03) 755-764
96 Rolando N, Harvey F, Brahm J. , et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol 1991; 12 (01) 1-9
97 Audimoolam VK, McPhail MJ, Willars C. , et al. Predicting fluid responsiveness in acute liver failure: a prospective study. Anesth Analg 2017; 124 (02) 480-486
98 Olson JC. Intensive care management of patients with cirrhosis. Curr Treat Options Gastroenterol 2018; 16 (02) 241-252
99 Olson JC, Wendon JA, Kramer DJ. , et al. Intensive care of the patient with cirrhosis. Hepatology 2011; 54 (05) 1864-1872
100 Chung C, Vaquero J, Gottstein J, Blei AT. Vasopressin accelerates experimental ammonia-induced brain edema in rats after portacaval anastomosis. J Hepatol 2003; 39 (02) 193-199
101 Eefsen M, Dethloff T, Frederiksen HJ, Hauerberg J, Hansen BA, Larsen FS. Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support. J Hepatol 2007; 47 (03) 381-386
102 Harry R, Auzinger G, Wendon J. The clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology 2002; 36 (02) 395-402
103 Audimoolam VK, McPhail MJ, Wendon JA. , et al. Lung injury and its prognostic significance in acute liver failure. Crit Care Med 2014; 42 (03) 592-600
104 Blonski W, Siropaides T, Reddy KR. Coagulopathy in liver disease. Curr Treat Options Gastroenterol 2007; 10 (06) 464-473
105 Kerr R, Newsome P, Germain L. , et al. Effects of acute liver injury on blood coagulation. J Thromb Haemost 2003; 1 (04) 754-759
106 Stravitz RT, Bowling R, Bradford RL. , et al. Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure. Hepatology 2013; 58 (01) 304-313
107 Scărlătescu E, Tomescu DR. Prothrombotic state in a patient with acute liver failure: the question of anticoagulation. Semin Cardiothorac Vasc Anesth 2018; 22 (02) 174-179
108 Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesth Analg 2009; 108 (03) 759-769
109 Munoz SJ, Rajender Reddy K, Lee W. ; Acute Liver Failure Study Group. The coagulopathy of acute liver failure and implications for intracranial pressure monitoring. Neurocrit Care 2008; 9 (01) 103-107
110 Brown JB, Emerick KM, Brown DL, Whitington PF, Alonso EM. Recombinant factor VIIa improves coagulopathy caused by liver failure. J Pediatr Gastroenterol Nutr 2003; 37 (03) 268-272
111 Pham HP, Hsu SX, Parker-Jones S, Samstein B, Diuguid D, Schwartz J. Recombinant activated factor VII in patients with acute liver failure with UNOS Status 1A: a single tertiary academic centre experience. Vox Sang 2014; 106 (01) 75-82
112 Vogel GE. Early treatment with AT III in acute liver failure. Behring Inst Mitt 1983; (73) 79-93 . PMID: 6679286
113 DellaVolpe J, Al-Khafaji A. Acute kidney injury before and after liver transplant. J Intensive Care Med 2018 Doi: 10.1177/0885066618790558
114 Jovanović I, Tešić M, Antonijević N. , et al. Acute renal failure and hepatocellular damage as presenting symptoms of type II aortic dissection. Srp Arh Celok Lek 2016; 144 (5-6): 320-324
115 Arora V, Maiwall R, Vijayaraghavan R. , et al. Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure. Hepatology 2018 Doi: 10.1002/hep.30208
116 Fujiwara K, Yasui S, Yokosuka O, Oda S, Kato N. A role of renal replacement therapy for acute liver failure. Hepatology 2018 Doi: 10.1002/hep.30081
117 Leventhal TM, Liu KD. What a nephrologist needs to know about acute liver failure. Adv Chronic Kidney Dis 2015; 22 (05) 376-381
118 McPhail MJ, Farne H, Senvar N, Wendon JA, Bernal W. Ability of King's College criteria and model for end-stage liver disease scores to predict mortality of patients with acute liver failure: a meta-analysis. Clin Gastroenterol Hepatol 2016; 14 (04) 516-525.e5 , quiz e43–e45
119 McPhail MJ, Wendon JA, Bernal W. Meta-analysis of performance of Kings's College Hospital criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol 2010; 53 (03) 492-499